Understanding prostate-specific antigen screening ...

Announcing a new article publication in BIO Integration. The tumor vasculature, characterized by pathological angiogenesis ...

New findings from VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM), published in ...

An MRI before treatment in men undergoing radical prostatectomy can provide independent prognostic value for oncologic ...

Precision Prostate Consulting, LLC announces its rebrand to DeepView Imaging, reflecting the company's mission to provide patients with direct, on-demand access to AI-powered prostate MRI analysis.

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...

Investigators developed and validated new PSMA-PET-based nomograms for prognostication across prostate cancer stages to help ...

Foley, was diagnosed with Stage 2 breast cancer in October. She owed her diagnosis to a secondary screening, similar to an ultrasound, biopsy or other diagnostic test. Now, ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...

For its 2nd anniversary, Callisto DataHub offers free annotated datasets of 50 suspected lung cancer X-rays and 50 ...

Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical study) procedure on the East Coast using the Vanquish(R) ...

An ultrasound-based treatment for prostate cancer showed better safety and operative metrics versus robotic radical ...